Barriers and facilitators to chemotherapy initiation and adherence for patients with HIV-associated Kaposi’s sarcoma in Kenya: a qualitative study

BACKGROUND: Kaposi sarcoma is one of the most prevalent HIV-associated malignancies in sub-Saharan Africa and is often diagnosed at advanced stage of disease. Only 50% of KS patients who qualify for chemotherapy receive it and adherence is sub-optimal. METHODS: 57 patients > 18 years with newly d...

Descripción completa

Detalles Bibliográficos
Autores principales: McMahon, Devon E., Singh, Rhea, Chemtai, Linda, Semeere, Aggrey, Byakwaga, Helen, Grant, Merridy, Laker-Oketta, Miriam, Lagat, Celestine, Collier, Sigrid, Maurer, Toby, Martin, Jeffrey, Bassett, Ingrid V., Butler, Lisa, Kiprono, Samson, Busakhala, Naftali, Freeman, Esther E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258164/
https://www.ncbi.nlm.nih.gov/pubmed/35794634
http://dx.doi.org/10.1186/s13027-022-00444-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258164/
https://www.ncbi.nlm.nih.gov/pubmed/35794634
http://dx.doi.org/10.1186/s13027-022-00444-0

Ejemplares similares